Clinical Trials By Condition
- Mycosis Fungoides
- Plaque Psoriasis
- Systemic Lupus Erythematosus
Systemic Lupus ErythematosusA Pilot, Phase 2, Randomized, Placebo-controlled, Double-blind, Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of a Thalidomide Derivative (CC-220) in Subjects with Systemic Lupus Erythematosus
If you are interested in posting your Clinical Trial on the Philadelphia Dermatological Society website, please Click Here to submit a request.